ATE421586T1 - Moraxella (branhamella) catarrhalis antigene - Google Patents
Moraxella (branhamella) catarrhalis antigeneInfo
- Publication number
- ATE421586T1 ATE421586T1 AT02742581T AT02742581T ATE421586T1 AT E421586 T1 ATE421586 T1 AT E421586T1 AT 02742581 T AT02742581 T AT 02742581T AT 02742581 T AT02742581 T AT 02742581T AT E421586 T1 ATE421586 T1 AT E421586T1
- Authority
- AT
- Austria
- Prior art keywords
- branhamella
- moraxella
- catarrhalis antigen
- catarrhalis
- antigen
- Prior art date
Links
- 241000588621 Moraxella Species 0.000 title abstract 2
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
- C07K14/212—Moraxellaceae, e.g. Acinetobacter, Moraxella, Oligella, Psychrobacter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Otolaryngology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Ophthalmology & Optometry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29840301P | 2001-06-18 | 2001-06-18 | |
| US33009501P | 2001-10-19 | 2001-10-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE421586T1 true ATE421586T1 (de) | 2009-02-15 |
Family
ID=26970641
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02742581T ATE421586T1 (de) | 2001-06-18 | 2002-06-18 | Moraxella (branhamella) catarrhalis antigene |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20050080233A1 (enExample) |
| EP (2) | EP2166096A3 (enExample) |
| JP (1) | JP2005508146A (enExample) |
| CN (1) | CN1582336A (enExample) |
| AT (1) | ATE421586T1 (enExample) |
| CA (1) | CA2455254A1 (enExample) |
| DE (1) | DE60230984D1 (enExample) |
| WO (1) | WO2002102836A2 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110540594B (zh) * | 2018-12-20 | 2021-05-11 | 湖北工业大学 | 基于卡他莫拉菌表面蛋白的乳胶微球免疫层析试纸的制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4431739A (en) | 1979-11-05 | 1984-02-14 | Genentech, Inc. | Transformant bacterial culture capable of expressing heterologous protein |
| US4425437A (en) | 1979-11-05 | 1984-01-10 | Genentech, Inc. | Microbial polypeptide expression vehicle |
| US4338397A (en) | 1980-04-11 | 1982-07-06 | President And Fellows Of Harvard College | Mature protein synthesis |
| GB9817824D0 (en) * | 1998-08-14 | 1998-10-14 | Smithkline Beecham Biolog | Novel compounds |
| CA2378687A1 (en) * | 1999-06-18 | 2000-12-28 | Elitra Pharmaceuticals, Inc. | Nucleotide sequences of moraxella catarrhalis genome |
-
2002
- 2002-06-18 EP EP09150805A patent/EP2166096A3/en not_active Withdrawn
- 2002-06-18 WO PCT/CA2002/000911 patent/WO2002102836A2/en not_active Ceased
- 2002-06-18 DE DE60230984T patent/DE60230984D1/de not_active Expired - Fee Related
- 2002-06-18 AT AT02742581T patent/ATE421586T1/de not_active IP Right Cessation
- 2002-06-18 US US10/481,248 patent/US20050080233A1/en not_active Abandoned
- 2002-06-18 EP EP02742581A patent/EP1399563B1/en not_active Expired - Lifetime
- 2002-06-18 CN CNA02812216XA patent/CN1582336A/zh active Pending
- 2002-06-18 CA CA002455254A patent/CA2455254A1/en not_active Abandoned
- 2002-06-18 JP JP2003506308A patent/JP2005508146A/ja not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002102836A2 (en) | 2002-12-27 |
| EP2166096A3 (en) | 2010-06-09 |
| US20050080233A1 (en) | 2005-04-14 |
| EP1399563B1 (en) | 2009-01-21 |
| EP2166096A2 (en) | 2010-03-24 |
| CN1582336A (zh) | 2005-02-16 |
| DE60230984D1 (de) | 2009-03-12 |
| WO2002102836A3 (en) | 2003-05-22 |
| CA2455254A1 (en) | 2002-12-27 |
| EP1399563A2 (en) | 2004-03-24 |
| JP2005508146A (ja) | 2005-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602004024542D1 (de) | Untereinheit-impfstoff gegen das respiratorische synzytialvirus | |
| ATE378403T1 (de) | Transchromosomale transgen-nagetiere zur herstellung von humänen antikörpern | |
| IL189629A0 (en) | Compositions containing human ctla-4 antibodies | |
| DE60233955D1 (de) | Spezifische bindungsmittel von human angiopoietin-2 | |
| CY1113224T1 (el) | Νεο αντισωμα αντι-ρlgf | |
| CY1114614T1 (el) | Αντιγονα αιμοφιλου ινφλουεντσας και αντιστοιχα dna θραυσματα | |
| DE60232862D1 (de) | Rekombinantes pockenvirus für chimäre proteine des menschlichen immunschwächevirus | |
| SE0203825D0 (sv) | Novel fused heterocycles and uses thereof | |
| ATE477274T1 (de) | Gegen clostridium difficile gerichtete antikörper | |
| ATE453714T1 (de) | Antigene aus cryptosporidium parvum, antikörper dagegen und diagnostische und therapeutische zusammensetzungen | |
| BR0113099A (pt) | Gene e proteìna relacionados com esquizofrenia | |
| ATE414154T1 (de) | Moraxella (branhamella) catarrhalis antigene | |
| DE60230984D1 (de) | Moraxella (branhamella) catarrhalis antigene | |
| DK1276495T3 (da) | Anvendelse af rekombinante lungesurfactant-præparater til tidlig behandling af akutte lungesygdomme | |
| TR200003345T2 (tr) | Moraxella Catarrhalıs'in bileşikleri | |
| DE69921649D1 (de) | Moraxella catarrhalis pilq proteine | |
| DE60229871D1 (de) | Moraxella (branhamella) catarrhalis polypeptide | |
| DE69928931D1 (de) | Moraxella catarrhalis polynukleotide und polypeptide | |
| WO2003018052A8 (en) | Moraxella (branhamella) catarrhalis polypeptides and corresponding dna fragments | |
| ATE293693T1 (de) | Moraxella catarrhalis antigen basb117 | |
| ATE293692T1 (de) | Moraxella catarrhalis antigen basb120 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |